BMRN
Biomarin Pharmaceutical Inc
57.20$
-2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +7.2% | +1.2% | +4.5% | +5.3% | +7.2% | +4.2% | -0.2% | +5.1% | -9.8% | +13.5% | -3.2% | +18.9% | -1.4% | +10.5% | -14.5% | +11.0% | -5.2% | +7.5% | +3.2% | -18.5% | +10.0% | +15.5% | +2.8% | -5.3% | +6.4% | +11.0% | -0.2% | -2.3% | +11.2% | +0.4% | +9.7% | +4.7% | +0.2% | -0.3% | +10.8% | -6.0% | +12.7% | -12.4% | +29.2% | – | |
| – | +26.4% | -22.0% | +12.6% | +5.6% | +27.8% | +8.3% | -4.0% | -0.2% | -4.9% | +18.9% | -13.2% | +25.2% | -1.1% | +16.1% | -12.0% | +92.7% | -33.2% | -4.7% | +5.7% | -18.5% | +15.7% | -2.3% | +5.3% | -5.6% | +9.5% | +6.4% | -3.6% | -2.0% | +5.8% | -7.6% | +4.2% | +44.5% | -27.8% | +11.3% | -1.0% | -6.7% | +110.7% | -33.9% | +4.0% | – | |
| – | +3.0% | +7.5% | +2.9% | +5.2% | +2.8% | +3.1% | +0.9% | +6.5% | -11.1% | +12.0% | -0.4% | +17.3% | -1.5% | +9.0% | -15.1% | -13.1% | +13.2% | +12.2% | +2.4% | -18.5% | +8.1% | +21.9% | +2.1% | -5.3% | +5.4% | +12.4% | +0.8% | -2.4% | +12.7% | +2.5% | +11.1% | -4.2% | +9.7% | -2.9% | +13.8% | -5.8% | -8.9% | -1.4% | +37.8% | – | |
| – | +9.0% | -17.3% | -1.4% | +7.7% | +9.4% | +9.1% | -4.5% | -8.1% | +8.7% | +4.7% | +1.1% | -6.8% | -0.1% | -17.7% | +28.0% | -19.3% | +6.5% | -5.1% | +8.3% | -2.0% | +2.0% | -0.2% | -1.6% | -0.2% | +9.5% | -0.5% | +3.2% | +7.9% | +7.8% | -0.6% | -10.3% | +0.6% | -6.2% | -8.5% | +1.6% | +153.8% | -53.0% | -7.1% | +15.7% | – | |
| – | +20.4% | -16.0% | +19.6% | -55.7% | +152.3% | -13.7% | +10.8% | -3.1% | +10.5% | -1.2% | -55.0% | +133.0% | +10.5% | -50.8% | -15.2% | +0.0% | +149.4% | -59.0% | +4.0% | +3.6% | +21.1% | -14.1% | -2.5% | +20.7% | +14.8% | -13.1% | -14.1% | -44.0% | +179.7% | -24.9% | +31.6% | +3.1% | -2.5% | -26.5% | +6.4% | +24.4% | +485.0% | -83.4% | +89.9% | – | |
| – | +12.6% | -15.9% | +9.5% | -3.9% | -22.2% | +49.6% | -4.9% | +3.0% | -3.7% | +15.5% | -3.8% | +2.4% | +2.1% | -22.3% | +30.4% | -7.7% | +7.8% | -8.1% | +6.5% | -1.2% | +10.5% | -33.1% | +40.2% | +5.4% | +11.1% | -8.3% | +0.1% | +5.9% | +17.4% | -12.4% | +6.0% | -3.8% | +1.4% | -17.8% | +7.8% | +71.4% | -26.8% | -11.7% | +53.1% | – | |
| – | – | – | – | – | – | -176.4% | – | – | – | – | – | – | -328.5% | – | -139.0% | – | – | – | -53.5% | -556.0% | – | – | -71.5% | -106.2% | – | – | +5.1% | -53.4% | -53.4% | +522.1% | +36.2% | -5.4% | +41.7% | +38.7% | +23.7% | -116.9% | – | +63.3% | -14.4% | – | |
| – | -2.5% | +4.0% | -0.8% | +8.4% | +7.2% | -0.9% | +5.7% | -0.8% | -36.1% | -13.2% | +2.1% | -57.2% | +136.0% | -0.2% | +16.4% | +19.2% | -50.5% | -19.9% | +0.3% | +1.4% | -0.6% | -1.0% | +1.4% | +21.2% | -22.5% | +2.1% | +1.4% | +0.6% | +61.4% | -41.8% | +0.8% | -17.0% | -13.2% | +11.1% | -6.4% | -3.7% | +7.7% | +438.4% | +323.2% | – | |
| – | – | – | – | – | – | -193.1% | – | – | – | – | – | – | -199.6% | – | -141.7% | – | – | – | -39.1% | -426.1% | – | – | -74.0% | -105.5% | – | – | +24.8% | -41.2% | -53.6% | +446.1% | +25.2% | +1.7% | +26.2% | +40.4% | +25.1% | -108.8% | – | – | -56.5% | – | |
| – | – | – | – | – | – | -106.3% | – | – | – | – | -226.8% | – | – | – | -165.5% | – | – | – | -79.3% | -895.6% | – | – | -46.3% | -33.9% | -464.6% | – | +150.1% | -91.3% | -181.2% | – | +47.8% | +13.6% | +57.6% | +17.2% | +9.4% | -92.3% | +339.4% | +83.7% | -53.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | -72.7% | +441.7% | -135.9% | – | -97.2% | -21.4% | -25.5% | -382.0% | – | – | -77.1% | -124.0% | – | – | +10.2% | -27.9% | -49.5% | +335.2% | +20.9% | -1.0% | +17.8% | +48.6% | +29.5% | -112.8% | – | – | -57.6% | – | |
| – | – | – | -498.9% | – | +857.9% | -117.7% | – | +498.0% | -163.4% | – | – | – | -48.4% | +498.4% | -107.1% | – | – | – | -17.8% | -134.2% | – | – | -61.3% | -56.9% | -63.6% | +766.4% | +15.1% | -28.9% | -27.3% | +164.0% | +18.9% | -3.6% | +25.0% | +34.5% | +21.3% | -101.6% | – | – | +28.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.